Morgan Stanley delivered a resilient QQ3 2024 performance with a top-line strength driven by capital markets activity and advisory flows. Revenue reached $26.328 billion, up 16.7% year over year and 3.3% quarter over quarter, supported by a diversified mix across Institutional Securities, Wealth Management, and Investment Management. Net income of $3.188 billion and diluted EPS of $1.88 underline solid profitability amid a cyclical environment, with an operating margin of approximately 16.0% (operating income of $4.221 billion on $26.328 billion of revenue).
However, the quarter also highlighted meaningful cash flow headwinds: operating cash flow was negative at $-17.323 billion and free cash flow was negative at $-18.239 billion, driven by working capital movements and other financing activities. The company finished the period with a robust liquidity position, including cash and short-term investments totaling about $434.537 billion and a strong balance sheet structure. Notably, Morgan Stanley continued returning capital to shareholders via share repurchases (~$806 million) and dividends (~$1.59 billion) while maintaining a prudent debt profile.
Valuation remains compelling on a price-to-book and price-to-earnings basis relative to global financial peers, with P/B around 0.41 and P/E around 3.36. Yet, the reported ROE of roughly 3.1% signals a substantial equity base relative to earnings, reminding investors that the firm’s profitability cadence is highly sensitive to market conditions and balance sheet dynamics. Going forward, investors should monitor capital markets activity, wealth management inflows, and regulatory developments, along with the trajectory of interest rates and macro volatility that drive Morgan Stanley’s earnings mix.